Top

Published in:

02-03-2023 | Choroidal Melanoma | Letter to the Editor

Trans-scleral uveal melanoma biopsy: can it be safely and accurately incorporated into a medium volume ocular oncology service?

Authors: Roderick F. O’Day, Penny McKelvie, Svetlana Cherepanoff, Daniel McKay

Excerpt

Dear editor, …

Carvajal RD, Schwartz GK, Tezel T et al (2017) Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol 101:38–44. https://doi.org/10.1136/bjophthalmol-2016-309034CrossRefPubMed

Robertson AG, Shih J, Yau C et al (2018) Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell 33:151. https://doi.org/10.1016/j.ccell.2017.12.013CrossRefPubMed

Frizziero L, Midena E, Trainiti S et al (2019) Uveal melanoma biopsy: a review. Cancers 11:1075. https://doi.org/10.3390/cancers11081075CrossRefPubMedPubMedCentral

Nathan P, Hassel JC, Rutkowski P et al (2021) Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med 385:1196–1206. https://doi.org/10.1056/NEJMoa2103485CrossRefPubMed

Lin V, Chung IY, Toumi E et al (2022) Biopsy for molecular risk stratification in uveal melanoma: yields and molecular characteristics in 119 patients. Clin Exp Ophthalmol 50:50–61. https://doi.org/10.1111/ceo.14022CrossRefPubMed

Title: Trans-scleral uveal melanoma biopsy: can it be safely and accurately incorporated into a medium volume ocular oncology service?
Authors: Roderick F. O’Day
Penny McKelvie
Svetlana Cherepanoff
Daniel McKay
Publication date: 02-03-2023
Publisher: Springer Netherlands
Keyword: Choroidal Melanoma
Published in: International Ophthalmology / Issue 7/2023
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-023-02647-9